12.3 ± 11.9 days. DAP was discontinued in 26 patients [need to switch to microbiological results (n = 19), bacterial pneumonia (n = 2), and increased creatine phosphokinase levels (n = 4)]. One patient had myalgia, while 9 received concomitant statins.
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INTRODUCTION Prosthetic vascular graft infection (PVGI) is a
severe complication of vascular surgery that carries high morbidity and mortality rates [1] [2] [3] . A surgical approach, combining excision of the graft, complete debridement of devitalized and infected tissues and maintenance of vascular flow to the distal bed, is consistently required, although some patients are not fit for operative intervention [1, 4] . [19, 20] suggest increasing the daily dose of DAP. Clinical experience with a dose [6 mg/kg is limited, but data reported to date suggest that DAP is safe and well-tolerated [20] [21] [22] .
In this report, we present our center's experience with high-dose DAP for empirical treatment of PVGI during the very crucial postoperative period, and as treatment adapted to microbiological results. 
METHODS

The
and periprosthetic collection (n = 24). Microbiological documentation was obtained in 21 patients (80.1%) despite previous antibiotic administration (n = 16) within the 2 days prior to DAP treatment: penicillin (n = 12), carbapenems (n = 1), glycopeptides (n = 6), fluoroquinolones (n = 4), glycylcyclines (n = 1), aminoglycosides (n = 2), or miscellaneous agents (n = 3). Cultures of (n = 6), acute renal failure (n = 5) including those requiring hemodialysis (n = 2), graft disruption (n = 4), and pneumonia (n = 2). A second surgical procedure was necessary for 10 patients during the same hospital stay, with a mean interval of 5.6 days, due to persistent infection in most cases. In 6 patients, vascular graft was removed and replaced by allo/ homograft. For the others, debridement was performed. New microorganisms were identified in 3 patients (Enterococcus sp. n = 1; Enterobacter sp. n = 2, E. coli n = 2, Candida sp. n = 1 [28, 29] , DAP has been linked to fully reversible skeletal muscle toxicity, with no effect on smooth or cardiac muscle. A significant rise in the CPK level was noted, from 2.5% to 8.3%. However, in the present study, it was not clear whether the rise in CPK levels was due to the higher dosage regimen and concomitant use of statins, or whether it was the effect of peri-operative status (i.e., time of clampage of the aorta, septic shock, concomitant use of vasopressive agents) [30, 31] . No eosinophilic pneumonia was observed in our study. 
CONCLUSION
In conclusion, results of the present study suggest that high-dose DAP (i. 
